Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03801382 · ClinicalTrials.gov registry record · NA
Psychometric Properties of IntelliSpace Cognition
A NA study, sponsored by Philips Electronics Nederland B.V. acting through Philips CTO organization.
- Completed
- Registry status
- NA
- Development phase
- 450
- Enrollment target
NCT03801382: Completed NA study, sponsored by Philips Electronics Nederland B.V. acting through Philips CTO organization.
NCT03801382 is a NA study that has completed, run by Philips Electronics Nederland B.V. acting through Philips CTO organization. The registered enrollment target is 450 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03801382, a NA study, has completed, sponsored by Philips Electronics Nederland B.V. acting through Philips CTO organization.
- COMPLETED
- Registry status
- NA
- Development phase
- 450 participants
- Enrollment target
Study Summary
This study aims to validate the tests that are on the IntelliSpace Cognition platform and to establish normative data for these tests.
Primary Outcome
Scores retrieved from all cognitive tests on the ISC platform The cognitive tests included on the ISC platform are commonly used in neuropsychological assessments and measure aspects of executive functioning (TMT A, TMT B, Star Cancellation Test, RAVLT, Letter Fluency Test, Category Fluency Test, ROCFT, Digit Span Forward, Digit Span Backward), processing speed (Star Cancellation Test), working memory (TMT A, TMT B, Star Cancellation Test, Letter Fluency Test, Digit Span Forward, Digit Span Back
Interventions
- DEVICE IntelliSpace Cognition (ISC)
- DIAGNOSTIC_TEST Paper-Pencil Tests
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2019-04-15 |
| Est. Completion | 2019-08-26 |
| Phase | NA |
What the finished NCT03801382 record still lists
NCT03801382 is an interventional study that assigns participants to a tested intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (68% lower).
The record links to 0 conditions, and to 2 interventions - of which IntelliSpace Cognition (ISC) is the first listed.
NCT03801382 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03801382 about?
NCT03801382 is a clinical study titled "Psychometric Properties of IntelliSpace Cognition". This study aims to validate the tests that are on the IntelliSpace Cognition platform and to establish normative data for these tests.
What is the current status of trial NCT03801382?
This trial is currently completed. It is a NA study. The enrollment target is 450 participants. The study started on 2019-04-15. Estimated completion is 2019-08-26.
What interventions are being tested in trial NCT03801382?
The interventions under investigation include: IntelliSpace Cognition (ISC) (DEVICE), Paper-Pencil Tests (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03801382?
This trial is sponsored by Philips Electronics Nederland B.V. acting through Philips CTO organization, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03801382's enrollment target sits among peer trials
450 225th of 2000 higher than 1,768 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03047161 · 450 participants
Electrophysiology of Fetal Arrhythmia
- NCT03269630 · 450 participants
New Orleans Pulmonary Hypertension Biobank
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI